In this call between colleagues, expert faculty discuss what they learned during the COVID-19 pandemic about strategies to care for patients with HCV infection, including patients who inject drugs.
In this engaging dialogue, 2 expert hepatologists discuss strategies for improving linkage to care of patients with viral hepatitis despite the challenges posed by the COVID-19 pandemic.
In this engaging dialogue, 2 expert hepatologists discuss strategies for maintaining care of patients with hepatocellular carcinoma and patients requiring liver transplantation despite challenges posed by the COVID-19 pandemic.
In this engaging dialogue, 2 expert hepatologists discuss strategies for maintaining and improving care of patients with HBV infection during the COVID-19 pandemic in the US and Asia, with lessons for across the world.
In this engaging dialogue between 2 hepatologists, expert faculty discuss strategies to maintain and improve screening and testing for hepatitis delta virus.
Review key slides from liver experts around the globe about lessons learned from the COVID-19 pandemic worth carrying forward.
The COVID-19 pandemic has provided the impetus for nimble and creative strategies that meet patients where they are. In the United States, telemedicine visits are one such strategy—and we should carry them forward in the delivery of care.
Here’s my take on how healthcare developments from the COVID-19 pandemic and simplified HCV screening, treatment, and monitoring can improve management for underserved populations.
As a patient, here are my strategies for maintaining viral hepatitis care and monitoring during the COVID-19 pandemic.
My thoughts on how to help patients cope with the diagnosis and treatment of hepatitis C and cirrhosis.
Strategies patients can use to cope with chronic hepatitis B include having frank conversations with healthcare professionals and engaging with patient advocacy groups.
Learn important data on the interplay of COVID-19 and viral hepatitis–related liver disease, including COVID-19 outcomes in patients with chronic liver disease (CLD) and expert guidance on clinical management, vaccination, and optimization of telemedicine for patients with CLD during the COVID-19 pandemic.
Key slides on COVID-19 and viral hepatitis–related chronic liver disease (CLD), including COVID-19 outcomes in patients with CLD and expert guidance on clinical management, vaccination, and optimization of telemedicine for patients with CLD during the COVID-19 pandemic.
Listen to insights from 2 expert faculty in this dialogue on lessons learned in the care of patients with HCV infection during the COVID-19 pandemic, including patients who inject drugs.
In this engaging dialogue, 2 expert hepatologists discuss strategies for improving linkage to care of patients with viral hepatitis despite the challenges posed by the COVID-19 pandemic.
In this engaging dialogue, 2 expert hepatologists discuss strategies for maintaining and even improving care of patients with HCC or liver transplantation despite the challenges posed by the COVID-19 pandemic.
In this engaging dialogue, 2 expert hepatologists discuss strategies for maintaining and improving care of patients with HBV infection during the COVID-19 pandemic in the United States and Asia, with lessons for around the world.
In this engaging dialogue, 2 expert hepatologists discuss strategies to maintain and improve screening and testing for hepatitis delta virus in the COVID-19 era.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.